Williams - Et - Al-2024-Intensive - Care - Medicine 2
Williams - Et - Al-2024-Intensive - Care - Medicine 2
Williams - Et - Al-2024-Intensive - Care - Medicine 2
https://doi.org/10.1007/s00134-024-07670-7
REVIEW
Abstract
Purpose: Low-value care is common in intensive care units (ICUs), unnecessarily exposing patients to risks and
harms, incuring costs to the patient and healthcare system, and contributing to healthcare’s carbon footprint. We
aimed to identify, collate, and summarise published evidence on the impact of interventions to reduce low-value care
in ICUs.
Methods: We searched MEDLINE, Embase, and Cochrane CENTRAL from inception to 22 September 2023 for evalu-
ations of interventions aiming to reduce low-value care, supplemented by reference lists and recently published
articles. We recorded impacts on the low-value target, health outcomes, resource use, cost, and the environment.
Results: From 1155 studies screened, 32 eligible studies were identified evaluating interventions to reduce: routine
blood testing (n = 13), routine chest X-rays (n = 10), and other types (or multiple types) of low-value care (n = 9). All
but 3 of the interventions found reductions in the immediate low-value care target (usually the primary outcome).
Although the small sample size of most included studies, limited their ability to detect impacts on other outcomes,
many interventions were also associated with improved health outcomes and financial savings. The only study that
reported environmental impacts found the intervention was associated with reduced carbon dioxide equivalent
(CO2-e) emissions.
Conclusions: Interventions to reduce low-value care in ICUs may have important health, financial, and environmen-
tal co-benefits. Further research may inform wider scale-up and sustainability of successful strategies to decrease
low-value healthcare. More empirical evidence on potential environmental benefits may inform policies to lower
healthcare’s carbon footprint.
Keywords: Intensive care, Low-value care, Health outcomes, Cost, Environmental impact, Review
*Correspondence: [email protected]
1
Faculty of Medicine and Health, School of Public Health, University
of Sydney, Sydney, NSW, Australia
Full author information is available at the end of the article
Introduction
Low-value care, also called overuse or unnecessary care, Take‑home message
refers to healthcare interventions with very little to
We aimed to identify, collate, and summarise published evidence on
no benefit to patients. In the intensive care unit (ICU), the impacts of interventions to reduce low-value care in intensive
thresholds to intervene tend to be lower and patients care units (ICUs). Multiple evidence-based interventions may reduce
are more vulnerable to the adverse effects of interven- low-value care in ICUs with important health, financial, and environ-
mental co-benefits. Further research may inform wider scale-up and
tions. As a result, low-value care is common [1–3], with sustainability of successful strategies to decrease low-value health-
critically unwell patients undergoing frequent diagnostic care. More empirical evidence on potential environmental benefits
imaging, pathology testing, treatments, and other proce- may inform policies to lower healthcare’s carbon footprint.
dures that have little or no benefit to them [2].
These interventions fail to improve patient health
were included in this review if they met the following
outcomes, with a recent meta-analysis reviewing inter-
participant, concept, and context (PCC) criteria:
ventions to reduce diagnostic tests in the ICU finding
that tests could be reduced without significant changes
• Participants: all critically unwell patients, including
to hospital mortality [4]. Low-value care also exposes
all health conditions and ages.
patients to risks and harms, uses up limited nurse and
• Concept: the effectiveness of interventions self-iden-
clinician time, has opportunity costs for patients and cli-
tifying to reduce the use of low-value care, includ-
nicians, and incurs financial costs for the patient, health
ing outcomes related to health, resource use, costs,
facility, and health system [5]. For all these reasons, there
and environmental impact. Resource use is broadly
is already good reason to reduce low-value care in the
defined and considered to include efficiency and
ICU.
more effective use of clinical staff ’s time (which may
However, there is also increasing awareness of the envi-
include continuing education to achieve this).
ronmental impacts of healthcare and the need to deliver
• Context: general intensive care settings, including
sustainable care [1, 6]. The Centre for Sustainable Health-
medical and surgical intensive care units (but not
care’s Principles of Sustainable Clinical Practice advocate
cardiac or cardiothoracic units).
for lean service delivery by reducing low-value activi-
ties and their impacts [7], and this is a compelling way
to make ICUs more sustainable [8]. To the best of our We identified peer-reviewed publications of inter-
knowledge, no review has sought to include the environ- vention studies, including randomised trials, non-ran-
mental benefits of reducing low-value care in the ICU. domised trials, and quality improvement studies, to
To inform further intervention and implementation identify the effectiveness of interventions to reduce low-
research to reduce low-value care in ICUs, we under- value care. Conference abstracts were excluded. Studies
took a scoping review of published evidence on the topic. published at any time and in any language were eligible
Specifically, we aimed to identify, collate, and summa- and translated using Google Translate (https://www.
rise evidence on the impacts of interventions to reduce google.com/translate) as required.
low-value care in hospital ICUs on health, resource use,
financial costs, and the environment. Information sources
We used the following automated tools from the System-
Methods atic Review-Accelerator [12] to develop our search: Word
Protocol and registration Frequency Analyser (uses pre-identified target papers to
This scoping review was conducted in accordance with identify common text words and MESH terms), Search
the Joanna Briggs Institute Manual for Evidence Synthe- Refinery (supports refinement of the search strategy
sis [9] and the protocol was registered with Open Sci- so that it is more efficient in finding relevant literature
ence Framework registry [10]. We report our findings and leaving out irrelevant literature) [13], and Polyglot
according to the Preferred Reporting Items for System- Translator (translates searches for MEDLINE to other
atic Reviews and Meta Analyses Extension for Scoping databases) [14]. We searched MEDLINE, Embase, and
Reviews (PRISMA-ScR) (electronic supplementary mate- Cochrane CENTRAL to identify potentially relevant
rial, ESM, 1) [11]. studies on 22 September 2023. The full search strategy
for each database is included in electronic supplementary
material, ESM, 2. This was supplemented by reference
Eligibility criteria lists from two recently published journal articles by Baid
Studies reporting on the effectiveness of interventions to et al. (references cited in “Avoid and reduce: tackling low-
reduce low-value care in hospital intensive care settings value care” section) [1] and Hooper et al. (all references)
[4]. We also included two recently published journal arti- records that were included in the review. Two of these
cles by Pilowsky et al. and Siegal et al. [15, 16]. reported on the same study [18, 19].
Identification
attributed to reduction in use of arterial blood gas tests 56%) [37]. The remaining seven studies reported inter-
[16]. Details are provided in Table 2 and ESM 4. ventions associated with fewer X-rays per patient or
patient-day (n = 6) [30, 32, 34–36, 39] or an increase
Reducing routine chest X‑rays in the proportion of X-rays that resulted in a change
Ten studies described interventions to reduce rou- in patient management (n = 1) [33]. All ten studies
tine chest X-rays, all of which were associated with an reported surrogate or direct health outcomes [30–39]
improvement in a low-value care outcome [30–39]. and most (n = 9) reported no changes [30–34, 36–39].
Three high-quality randomised studies reported fewer In one study, the intervention was associated with a
X-rays per patient-day (1.09 vs 0.75) [38], and per decrease in the proportion of patients requiring pul-
patient (6.8 vs 4.4) [31], and an improvement in the monary artery catheters [35]. Five studies reported
proportion of tests with new findings (7.2% vs 66%) financial outcomes, all of which suggested cost savings
[37] that prompted a change in management (5.5% vs [30, 33–36]. No environmental impacts were reported.
Details are provided in Table 3 and ESM 4.
Table 1 Characteristics of 32 included studies
Author, year Quality Country ICU setting Study design Type of low-value care Sample size
Pilowsky (2024) [16] Level 4 Australia Adult QIS Routine pathology tests 22,210 patients
Siegel (2023) [15] Level 2 Canada Adult Stepped-wedge cluster-ran- Blood tests (volume) 27,411 patients
domised trial
Bodley (2023) [20] Level 4 Canada Adult QIS Blood collection volume, 2096 patients
including for pathology test-
ing and waste
Malin (2023) [36] Level 4 USA Child QIS CXR 668 patients
Conroy (2021) [22] Level 4 USA Adult QIS Routine pathology tests 24 bed ICU
Ogasawara (2020) [45] Level 4 Japan Adult and Child QIS Stress ulcer prophylaxis 100 patients
Clouzeau (2019) [21] Level 3 France Adult Prospective cohort study Laboratory tests 5707 patients
Dhanani (2018) [23] Level 4 Australia Adult QIS Laboratory blood tests 3250 patients
Yorkgitis (2017) [46] Level 4 USA Adult QIS Blood tests, CXR 307 patients
Brogi (2017) [30] Level 3 Italy Adult Retrospective cohort study CXR 4134 patients
Kotecha (2017) [24] Level 4 USA Adult QIS Unnecessary laboratory tests 207 patient-daysa
Keveson (2017) [34] Level 4 USA Adult QIS CXR 2 × 21 bed ICUs
Raad (2017) [41] Level 4 USA Adult QIS Blood tests 18 bed ICU
Rachakonda (2017 [27] Level 4 Australia Adult QIS Laboratory tests 2778 patients
Resnick (2017) [39] Level 4 USA Adult QIS CXR 197 patients
Musca (2016) [26] Level 4 Australia Adult QIS Coagulation blood tests 253 patients
Murphy (2016) [40] Level 4 USA Adult QIS Blood tests, CXR 22,563 patients
Merkeley (2016) [25] Level 4 Canada Adult QIS Blood tests 1140 patients
Gutsche (2013) [43] Level 4 USA Adult QIS Blood transfusions 495 patients
Hejblum (2009) [38] Level 2 France Adult Cluster randomised crossover CXR 849 patients
study
Prat (2009) [44] Level 4 France Adult QIS CXR, blood tests 1175 patients
Kumwilaisak (2008) [28] Level 4 USA Adult QIS Blood tests 1117 patients
Graat (2007) [32] Level 4 Netherlands Adult QIS CXR 1376 patients
Hendriske (2007) [33] Level 4 Netherlands Adult QIS CXR 736 patients
Clec’h (2007) [37] Level 2 France Adult Randomised controlled trial CXR 165 patients
Krinsley (2003) [35] Level 4 USA Adult QIS CXR 2564 patients
Krivopal (2003) [31] Level 3 USA Adult Pseudo-randomised study CXR 94 patients
Seguin (2002) [47] Level 4 France Adult QIS Blood tests, CXR 289 patients
Mehari (2001) [19]b Level 4 NZ Adult QIS Blood tests 94 patients
Merlani (2001) [29] Level 4 Switzerland Adult QIS Blood tests 549 patients
Mehari (1997) [18]b Level 4 NZ Adult QIS Blood tests 199 patients
Roberts (1993) [42] Level 4 Canada Adult QIS blood tests, CXR, ECG 1883 patients
CXR chest X-Ray, ECG electrocardiogram, ICU intensive care unit, NZ New Zealand, QIS quality improvement study, USA United States of America
a
Number of participants not reported
b
Report on the same study
Reducing other types of low‑value care or multiple types trial found that smaller volume blood test tubes resulted
of low‑value care in 10 fewer blood units transfused per 100 patients dur-
Six studies aimed to reduce both laboratory testing and ing their ICU stay [15]. In the seven studies that meas-
diagnostic imaging, [40–42, 44, 46, 47] of which five were ured health outcomes, these were no worse under
associated with an improvement in a low-value care out- intervention than control [15, 40–43, 45, 46]. Four stud-
come [40–42, 44, 47]. Two studies aimed to reduce blood ies reported financial outcomes, all of which suggested
transfusions [15, 43], and one aimed to reduce use of cost savings [40, 42, 44, 47]. No environmental impacts
stress ulcer prophylaxis [45], all of which were associated were reported. Details are provided in Table 4 and ESM
with an improvement in a low-value care outcome. A 4.
large high-quality stepped wedge randomised controlled
Table 2 Impacts of 13 studies reporting interventions to reduce routine blood testing
Author Quality Intervention Low-value care outcomes Health outcomes Financial outcomes Environmental outcomes
Pilowsky (2024) [16] Level 4 Education, audit, feedback 1.7 fewer pathology tests per 12% fewer patients receiving AUD 918,497.50 saved per year 1.83 less tonnes CO2-e
patient-day (8.68 vs 6.98) mechanical ventilation (37.8 (group results not reported) emitted per year (12.88
vs 33.1; p < 0.001) vs 11.05)
1.5 less hours in ICU (50.6 vs
49.1; p = 0.032)
Bodley (2023) [20] Level 4 Education, bedside checklist, 1.4 fewer blood collection 2.2 fewer red cell transfusions NA NA
electronic order modifica- tubes per patient-day (6.3 vs per 100 patient-days (10.5 vs
tions, audit, feedback 4.9; p = 0.005) 8.3; p = 0.01)
7 mL less blood collected for
testing per patient-day (41.1
vs 34.1; p = 0.009)
Conroy (2021) [22] Level 4 Education, adjusting test 1.2 fewer laboratory tests per No change NA NA
ordering set patient-day (9.5 vs 8.3)
Clouzeau (2019) [21] Level 3 Education, new ordering 22.1 fewer tests per ICU- No change Euro 135 saved per patient- NA
policy patient-day (37.3 vs 15.2; day (239 vs 104; p < 0.0001)
p < 0.001)
Dhanani (2018) [23] Level 4 Prescribing guidelines, new 1.3 fewer pathology tests per No change AUD 28.26 saved per patient NA
laboratory form, education patient-day (4.7 vs 3.4) per day (group results not
reported)
Kotecha (2017) [24] Level 4 Guidelines, education 2.1 fewer tests per patient-day NA NA NA
(3.5 vs 1.4)
Rachakonda (2017) [27] Level 4 Authorisation of blood tests by NA NA No change NA
ICU specialist
Merkeley (2016) [25] Level 4 Education, ICU checklist, a rub- 0.14 fewer routine complete No change CAD 11,200.24 saved per year
ber stamp indicating tests blood count tests per (group results not reported)
not indicated, prompt in patient-day (0.97 vs 0.83)
electronic ordering system 0.13 fewer routine electrolyte/
renal panel tests per patient-
day (0.96 vs 0.83)
Musca (2016) [26] Level 4 Guideline, education 0.529 fewer coagulation 1.79 mL less blood collected USD 17.23 saved per bed-day NA
profile tests per patient-day for coagulation testing per (28.47 vs 11.24)
(1.068 vs 0.539; p < 0.001) patient-day (group results
0.437 fewer coagulation pro- not reported)
file, activated partial throm-
boplastin time, international
normalised ratio tests per
patient-day (1.088 vs 0.651;
p < 0.001)
0.685 fewer full blood count,
urea, electrolytes and
creatine, and liver function
tests per patient-day (5.367
vs 4.682; p = 0.003)
Discussion
Environmental outcomes
NA
NA
feedback. Most studies reported associations with mod-
erate reductions in low-value care (the immediate target
for cardiac ICU (group results
NZD 64.61 saved per patient
No change
post-implementation (1997
general ICU (61.04 vs 53.34)
AUD Australian Dollar, CAD Canadian Dollar, CHF Swiss Franc, NZD New Zealand Dollar, USD United States Dollar
study’s literature search period) [15, 16, 20–22, 24, 36, 43,
(20.7 vs 16.4; p < 0.001)
Guideline
Level 4
outcomes [49].
Health benefits and economic savings provide compel-
ling arguments to increase efforts to limit low-value care
Table 2 (continued)
Malin (2003) [36] Level 4 Criteria for CXR 48% absolute difference in proportion of No change USD 300,000 saved to patients over study
intubated patients receiving daily CXR period (group results not reported)
(79% vs 31%) USD 60,000 saved to hospital over study
period (group results not reported)
Brogi (2017) [30] Level 3 Routine use of lung ultrasound 0.55 fewer CXRs per patient (0.97 vs 0.42) No change Euro 22,104 saved over study period
(47,090 vs 24,986; p = 0.012)
Keveson (2017) [34] Level 4 Clinically indicated CXR, education 589 fewer CXRs per 1000 non-admission No change USD 191,600 saved per year in medical ICU
and non-procedural days in medical (group results not reported)
ICU (919 vs 330; p < 0.001) USD 224,200 saved per year in surgical ICU
346 fewer CXRs per 1000 non-admission (group results not reported)
and non-procedural days in surgical ICU
Resnick (2017) [39] Level 4 Guideline, clinically indicated CXR 16.2% fewer CXRs per patient-day (57.1 vs No change NA
40.9; p < 0.01)
Hejblum (2009) [38] Level 2 Clinically indicated CXR 0.34 fewer CXRs per patient-day of No change NA
mechanical ventilation (1.09 vs 0.75;
p < 0.0001)
Clec’h (2008) [37] Level 2 Clinically indicated CXR 58% absolute difference in proportion of No change NA
CXRs with new findings (7.2% vs 66%;
p < 0.0001)
50.9% absolute difference in proportion
of CXRs prompting change in manage-
ment (5.5% vs 56.4%; p < 0.0001)
Graat (2007) [32] Level 4 Clinically indicated CXR 0.5 fewer CXRs per patient-day (1.1 vs 0.6; No change NA
p < 0.05)
Hendrikse (2007) [33] Level 4 Clinically indicated CXR 16% absolute difference in proportion of No change Euro 82,500 saved per year (group results
CXRs prompting change in manage- not reported)
ment (1.9% vs 17.9%; p < 0.001)
Krinsley (2003) [35] Level 4 Form indicating the reason every 0.135 fewer CXRs per patient-day (0.606 4.5% absolute difference in proportion USD 109,968 saved over study period
CXR was ordered vs 0.471; p < 0.0001) of patients requiring pulmonary artery (group results not reported)
catheters (8.5% vs 4%; p < 0.0001)
Krivopal (2003) [31] Level 3 Clinically indicated CXR 2.2 fewer CXRs per patient (6.8 vs 4.4; No change NA
p = 0.007)
CXR chest X-ray, USD United Stated Dollar
Table 4 Impacts of nine studies of interventions to other types of low-value care or multiple types of low-value care
Author Quality Intervention Low-value care outcomes Health outcomes Financial outcomes
Siegal (2023) [15] Level 2 Small-volume tubes Standard-volume tubes in ICU storage 9.84 less red blood cell units transfused NA
areas post-intervention were 0.02%- per 100 patients during ICU stay (0.8
2.9% of total tubes counted vs 0.71; p = 0.04)
Ogasawara (2020) [45] Level 4 Checklist, change to ordering system 62% absolute difference in the propor- No change NA
tion of patients receiving stress ulcer
prophylaxis (100% vs 38%; p < 0.001)
Raad (2017) [41] Level 4 Education, electronic medical record 12.48 fewer laboratory tests per No change NA
changes patient-day (39.43 vs 26.95; p < 0.001)
6.21 fewer iSTAT laboratory tests per
patient-day (7.37 vs 1.16; p < 0.001)
Yorkgitis (2017) [46] Level 4 Daily checklist change No change No change NA
Murphy (2016) [40] Level 4 Education, financial incentives, feed- 1.6 fewer arterial blood gas tests per 1.7% lower absolute risk of ICU mortal- USD 772,048 saved per year
back encounter (3.9 vs 2.3; p < 0.005) ity (6.3% vs 4.6%; p < 0.005)
1.1 fewer CXR per encounter (3.5 vs 2.4; 1.8% lower absolute risk of hospital
p < 0.005) mortality (7% vs 5.2%; p < 0.005)
0.1 fewer utilised red blood cell units
per encounter (0.6 vs 0.5; p < 0.005)
Gutsche (2013) [43] Level 4 Clinical practice guideline, education, 6.6% absolute difference in unneces- No change NA
feedback sary transfusions (14.7% vs 8.1%;
p = 0.0016)
Prat (2009) [44] Level 4 Guideline, education, feedback 0.3 fewer CXRs per patient-day (0.75 vs NA Euro 58 saved per patient ICU day (114
0.45; p < 0.001) vs 56)
0.11–0.56 fewer routine laboratory tests
per patient (varied depending on the
type of test, see ESM 4)
Seguin (2002) [47] Level 4 Inform physicians of test costs 0.63 fewer urinary electrolyte tests per NA Euro 75 saved per admission (341 vs 266;
admission (1.16 vs 0.53; p < 0.01) p < 0.05)
0.8 fewer arterial blood gas tests per
admission (1.84 vs 1.04; p = 0.01)
Roberts (1993) [42] Level 4 Policy change 18% fewer tests per ICU day (42.6 vs No change CAD 121.84 saved per admission
34.9)
CAD Canadian Dollars, ICU intensive care unit, iSTAT laboratory tests available though point of care
Only one of the included studies investigated envi- decrease in low-value care. To achieve this, studies may
ronmental benefits from limiting low-value care. There also investigate if a particular type of intervention is more
is increasing recognition that not only does climate effective than others and whether this varies by type of
change impact health, but that health care itself is pol- low value care, and by setting. Such evidence would ena-
luting and contributes substantially to the greenhouse ble policy makers and clinicians to choose the most effec-
gas emissions driving the climate crisis [51]. Most of tive and efficient strategy that best addresses their needs.
these emissions come directly from healthcare prod-
Supplementary Information
ucts and the delivery of healthcare services. This means The online version contains supplementary material available at https://doi.
that to achieve net zero health systems, we must lower org/10.1007/s00134-024-07670-7.
the footprint of clinical care itself [2, 3]. The ICU is a
carbon hotspot within hospitals, which themselves Author details
account for a large proportion of healthcare’s total foot- 1
Faculty of Medicine and Health, School of Public Health, University of Sydney,
print [1]. Interventions that are effective in reducing Sydney, NSW, Australia. 2 Western Health, Sunshine Hospital, Melbourne, VIC,
Australia. 3 Department of Critical Care, University of Melbourne, Melbourne,
low-value care in the ICU will, therefore, help reduce VIC, Australia. 4 Department of Anaesthesia, Western Health, Footscray, VIC,
healthcare’s CO2-e emissions. Increased implementa- Australia. 5 Department of Intensive Care, Western Health, Footscray, VIC,
tion of “less is more” interventions are likely to have Australia. 6 Centre for Sustainable Healthcare, Oxford OX2 7DL, UK. 7 Agency
for Clinical Innovation, St Leonards, NSW, Australia. 8 Faculty of Medicine
significant co-benefits across health, costs, and envi- and Health, Kolling Institute, University of Sydney, Sydney, NSW, Australia.
ronmental outcomes [52]. 9
Sydney School of Medicine (Nepean Clinical School), University of Sydney,
Strengths of this scoping review are the multidiscipli- Kingswood, NSW, Australia.